High concentrations of recombinant soluble CD4 are required to neutralize primary human immunodeficiency virus type 1 isolates. [electronic resource]
Producer: 19901011Description: 6574-8 p. digitalISSN:- 0027-8424
No physical items for this record
Publication Type: Journal Article; Research Support, Non-U.S. Gov't; Research Support, U.S. Gov't, P.H.S.
There are no comments on this title.
Log in to your account to post a comment.